文献速递中医内科中药与中成药合理使用

证型辨证是否影响疗效:麻子仁丸治疗功能性便秘随机对照试验研究方案

Whether Syndrome Differentiation Affects Treatment Result: Study Protocol of MaZiRenWan () for Functional Constipation in A Randomized Controlled Trial.
PubMed 文献 · Chin J Integr Med · 2018-08-14

本研究为18周前瞻性双盲双模拟随机对照试验,拟纳入120例辨证为燥热证的功能性便秘患者,随机分为固定麻子仁丸组、辨证加减麻子仁丸组和比沙可啶组。主要终点为治疗期间每周完全自发排便次数均值,旨在评估辨证论治对中成药疗效的影响。

要点

  • 以燥热证功能性便秘为载体,检验辨证加减是否优于固定麻子仁丸。
  • 三组对照设计:固定麻子仁丸、辨证加减麻子仁丸、比沙可啶。
  • 主要终点为治疗期每周完全自发排便次数均值。

核心结论

  • 本试验旨在评估固定麻子仁丸、辨证加减麻子仁丸和比沙可啶对燥热证功能性便秘患者的疗效,并探讨辨证论治对中成药疗效的重要性。

研究设计与样本

  • 18周前瞻性双盲双模拟随机对照试验,含2周导入期、8周治疗期和8周随访期。
  • 拟从天津中医药大学第一附属医院和天津中医药大学保康附属医院招募120例燥热证功能性便秘患者。
  • 患者随机分配至固定麻子仁丸颗粒组、辨证加减麻子仁丸颗粒组或比沙可啶组。

关键数值与推荐

  • 辨证加减麻子仁丸组根据个体辨证最多可添加两种中药颗粒。
  • 主要终点为治疗期间每周完全自发排便次数均值。
  • 次要终点包括随访期每周完全自发排便次数均值、粪便性状、总体症状改善、便秘及相关症状评估、中医证候变化及不良事件报告。

临床怎么用

  • 试验结果可为功能性便秘燥热证患者使用麻子仁丸时是否需要辨证加减提供证据。
  • 研究设计关注中医证候变化与疾病进展,有助于理解辨证论治在方剂疗效中的作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Syndrome is one of the most important concepts in Chinese medicine (CM) theory. However, it was not well accounted in most of randomized controlled trials (RCTs). OBJECTIVES: To determine whether CM syndrome differentiation affects the treatment results, functional constipation (FC) was selected as a target disease, and MaZiRenWan (, MZRW), a classic CM formula commonly used for constipation with excessive heat syndrome, was selected for study. METHODS: It is an 18-week prospective double-blinded, doubledummy RCT, including 2-week run-in, 8-week treatment and 8-week post treatment follow-up. A total of 120 FC patients diagnosed as excessive heat syndrome will be recruited from the First Teaching Hospital of Tianjin University of Traditional Chinese Medicine and the Baokang Affiliated Hospital of Tianjin University of Traditional Chinese Medicine. Patients will be randomly allocated into fixed MZRW (f_MZRW) granule group, modified MZRW (m_MZRW) granule group or bisacodyl group. For m_MZRW group, no more than two herbal granules can be added according to the syndrome differentiation for individual participants. The primary end point is the mean of complete spontaneous bowel movements (CSBMs) per week during the treatment period. Secondary end points include mean of CSBMs per week during follow-up, stool form, global symptom improvement, constipation and constipation-related symptoms assessment, CM syndrome change, and reported adverse events. DISCUSSION: This trial is designed to evaluate the effectiveness of these three interventions for FC patients with the CM syndrome of excessive heat, and to determine the change of CM syndrome and the progress of disease during the treatment course. The results are important to explore whether syndrome differentiation is important for the therapeutic effect of a formula on a disease. [Trial registration: Chinese Clinical Trial Registry (Reg No. ChiCTR-TRC-13003742); protocol version: MZRW/NSFC-81173363 (2015.05.04)].

来源:Chin J Integr Med,查看原文。版权归原作者所有。

引用

  1. Cheng CW, Zhang L, Zhao C, et al. Whether Syndrome Differentiation Affects Treatment Result: Study Protocol of MaZiRenWan () for Functional Constipation in A Randomized Controlled Trial. Chin J Integr Med. 2018. PMID: 30109589. doi:10.1007/s11655-018-2848-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。